VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
DBD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
DBDDiebold Nixdorf, Incorporated
$58.27$2.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksDBDCash Flow

Diebold Nixdorf, Incorporated (DBD) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow margin swung from 18.8% in 2024Q4 to -6.1% in 2026Q3, with working capital changes of -$96.1M in the latest quarter suggesting cash generation remains lumpy and driven by timing rather than a consistent operating trend.

Income StatementBalance SheetCash FlowRatios

DBD Cash Flow Statement

Annual statement

DBD Cash Flow Statement

Diebold Nixdorf, Incorporated (DBD) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations180.9M300.7M149.2M-257M-387.9M123.3M18M135.8M-104.1M37.1M28.4M36.7M186.91M124.22M135.51M215.4M273.35M300.85M281.15M150.26M250.42M116.86M232.65M209.9M163.5M154.36M146.19M188.6M177.2M111.3M93.6M
Operating CF Margin %-7.9%3.98%-6.83%-11.21%3.16%0.46%3.08%-2.27%0.8%0.86%1.52%6.13%4.35%4.53%7.6%9.68%11.07%8.87%5.07%8.62%4.52%9.77%9.95%8.43%8.77%8.38%14.98%14.94%9.07%9.09%
Operating CF Growth %-283.41%101.54%158.05%33.75%-414.6%585%-86.75%230.45%-380.59%30.63%-22.62%-80.36%50.46%-8.33%-37.09%-21.2%-9.14%7.01%87.11%-40%114.28%-49.77%10.84%28.38%5.92%5.58%-22.48%6.43%59.21%18.91%31.46%
Net Income76.7M94.6M-14.5M1.38B-585.6M-78.8M-269.1M-341.3M-566M-241.5M-176.7M57.8M117.02M-176.52M84.4M152.1M-16.68M47.84M106.41M39.54M86.55M96.75M183.96M174.78M99.15M66.89M136.92M128.9M76.1M122.5M97.4M
Depreciation & Amortization124.4M127.5M132.3M136.3M126M149.1M180.4M226.1M247.8M252.2M134.8M-64M74.07M82.59M78.64M79.86M79.25M77.69M80.47M63.38M69.81M76.24M74.98M64.3M61.3M45.45M35.9M34.7M25.6M28.5M33M
Stock-Based Compensation11.7M09.7M013.4M00036.6M33.9M22.2M12.4M21.55M15.43M13.84M14.3M12.54M11.91M12.19M13.78M00000000000
Deferred Taxes-26.7M-48.1M-34.1M36.6M92.9M-12.6M-27.1M54.2M-59.6M16.6M-94.6M-40.1M-11.3M-15.13M-10.56M-29.34M-47.78M50.38M-12.55M9.57M-38.39M10.06M28.49M-10.17M12.98M-27.45M15.3M8.5M-4.2M1.1M-5.3M
Other Non-Cash Items-55.2M60.9M17.2M-1.62B135.4M36.2M135.5M81.2M293.3M537.3M191.9M35.8M10.33M12.55M10.09M8.87M-35.16M77.29M18.53M59.18M37.89M-9.04M8.13M8.09M45.68M67.28M39.92M-100K15.7M11.4M17.4M
Working Capital Changes48.2M65.8M38.6M-182.5M-170M29.4M-1.7M115.6M-56.2M-62.5M151.5M-82.5M-15.31M77.56M-53.41M-28.39M70.09M95.53M75.74M-23.39M88.25M-57.14M-62.91M-27.1M-55.61M2.18M-81.85M-7.6M23.5M-58.4M-53.9M
Change in Receivables-7.7M25.9M99.6M-91.7M-49.4M16.4M-19.7M111.5M51M23.9M78.9M-22.6M-58.59M23.98M-75.28M-22.79M-69.38M123.4M60.22M107.5M00000000000
Change in Inventory27.2M65.1M20.9M52.7M-74.5M-84.8M-14.8M104.9M-5.1M21.8M124.3M-51.2M-53.24M21.34M20.95M-12.6M3.14M76M-53.65M8.96M-24.77M-23.56M-52.43M-10.54M4.69M-27.5M-7M-4.6M200K-18.7M-18.4M
Change in Payables41.9M-68.3M-42.2M-65.4M-66.5M241.4M10.6M-33.1M-34.5M-6.3M-112.1M57.6M59.28M-9.66M2.56M11.74M65.77M-54.19M36.48M6.33M00000000000
Cash from Investing-47.1M-97.6M-45.5M-36.1M-23.8M-36.5M-82.6M-6.8M34.4M-120.8M-561.4M-64.9M13.8M-52.72M-72.83M-90.71M-164.76M-93.23M-142.48M-80.37M-182.08M-120.41M-184.31M-82.08M-6.85M-138.53M-215.36M-281.8M-96.5M-102.7M-52.5M
Capital Expenditures-48.1M-61.7M-17.4M-47.8M-53.1M-51.3M-44.7M-56.2M-58.5M-102.5M-67.7M-58.6M-61.45M-35.45M-49.74M-54.75M-51.3M-44.29M-57.93M-43.26M-44.28M-62.6M-61.24M-72.82M-50.34M-68.66M-42.69M-199.4M-30.8M-67.7M-33.6M
CapEx % of Revenue1.23%1.62%0.46%1.27%1.53%1.31%1.15%1.27%1.28%2.22%2.04%2.42%2.01%1.24%1.66%1.93%1.82%1.63%1.83%1.46%1.52%2.42%2.57%3.45%2.59%3.9%2.45%15.84%2.6%5.52%3.26%
Acquisitions-24.5M-24.5M0010.5M15.5M-26.8M29.9M-5.9M15.3M-853.3M-54.4M-11.75M35.45M-28.29M2.52M1.81M-5.36M-4.46M-18.12M-62.16M-27.7M-62.22M-10.61M-3.68M-36.77M-143.33M0000
Investments-------------------------------
Other Investing37.6M1M-21.7M06M015.6M0181.4M-20.2M378.1M-2.5M-1.35M92K6.44M8.96M-28.56M-43.58M-80.09M-29.08M-36.94M-38.63M-33.11M-24.31M7.7M-77.77M-72.75M-46.1M-29.4M-42.6M-10.1M
Cash from Financing-156M-143.9M-366.5M559.5M349.8M-16.3M16.9M-215.5M10.9M-63.7M881.6M42.2M-81.15M-204.45M-36.23M-123.53M-111.1M-132.5M-84.17M-135.28M-24.06M27.22M-37.57M-119.93M-76.48M-4.01M107.05M78M-58.5M-10.2M-35M
Debt Issued (Net)00-300.1M565.2M376.1M-7.3M91.6M-115.5M398.8M-10.8M958M116.9M-15.9M-126.7M23.63M61.31M-15.96M-61.46M-17.77M-64.06M170.41M214.54M79.69M-54.83M-27.61M-30.19M144.81M117.5M020.8M0
Equity Issued (Net)-85M-130.7M00000-1.9M-3M-4.7M-1.9M500K12.7M12.6M13.23M-107.77M-22.44M-404K08.54M-136.34M-138.21M-63.48M7.75M6.24M-7.7M7.1M2.7M-3.7M4.8M1.2M
Dividends Paid00000000-7.7M-30.6M-64.6M-75.6M-74.95M-74M-72.83M-72.9M-71.9M-69.45M-66.56M-62.44M-57.41M-57.77M-53.24M-49.24M-47.53M-45.77M-44.27M-41.7M-38.6M-34.5M-31.2M
Share Repurchases-85M-130.7M00000-1.9M-3M-5M-2.2M-3M-1.92M-4.1M-3.45M-111.81M-25.77M-1.92M00-148.06M-138.21M-71.9M-12.37M-1.47M-12.78M-2.3M-1.2M-8.3M00
Other Financing-71M-13.2M-66.4M-5.7M-26.3M-9M-74.7M-98.1M-377.2M-17.6M-9.9M-100K-3.01M-16.35M-249K-4.18M-800K323K-3.35M-17.32M-718K8.66M-540K-23.61M-7.57M79.65M-590K-500K-16.2M-1.3M-5M
Net Change in Cash-24.6M76M-281M273.2M-69.8M64.4M43.6M-177.5M-84.8M-109.5M339.1M-12.5M91.31M-138.08M34.87M5.26M232K86.99M35.1M-47.63M45.91M23.86M14.09M14.51M81.68M8.58M37.88M-15.2M-58.5M-10.2M-35M
Free Cash Flow139.8M263.3M131.8M-281.9M-441M72M-26.7M92.9M-162.6M-65.4M-39.3M-21.9M125.45M88.78M85.77M160.64M222.06M256.56M223.22M107M206.15M54.26M171.41M137.08M113.16M85.7M103.5M-10.8M146.4M43.6M60M
FCF Margin %3.57%6.92%3.51%-7.5%-12.74%1.84%-0.68%2.11%-3.55%-1.42%-1.19%-0.91%4.11%3.11%2.87%5.66%7.86%9.44%7.04%3.61%7.09%2.1%7.2%6.5%5.83%4.87%5.94%-0.86%12.35%3.55%5.82%
FCF Growth %-39.09%99.77%146.75%36.08%-712.5%369.66%-128.74%157.13%-148.62%-66.41%-79.45%-117.46%41.31%3.51%-46.61%-27.66%-13.45%14.94%108.62%-48.09%279.92%-68.34%25.04%21.13%32.05%-17.2%1058.34%-107.38%235.78%-27.33%67.13%
FCF per Share4.047.083.51-4.38-5.580.92-0.341.21-2.14-0.87-0.57-0.331.931.391.342.483.373.843.361.603.070.762.361.881.571.191.45-0.162.110.630.87
FCF Conversion (FCF/Net Income)1.82x3.18x-9.04x-0.19x0.67x-1.56x-0.07x-0.40x0.18x-0.15x-0.16x0.48x1.63x-0.68x1.73x1.49x-13.50x7.23x3.01x3.80x2.89x1.21x1.26x1.20x1.65x2.31x1.07x1.46x2.33x0.91x0.96x
Interest Paid00149.4M0231.6M000129.6M99.9M85.4M32.6M31.2M29.5M28.92M30.71M32.05M24.49M30.75M000000000000
Taxes Paid0056.1M033.1M00064.9M78.2M83.8M64.8M49.2M76.5M49.01M27.47M15.86M34.29M42.15M000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Negative operating cash flow recently

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Earnings Not Backed by Operating Cash

According to reported quarterly figures, DBD's operating cash flow was negative in three of the last four quarters, including -$47.4M in 2026Q3, while net income remained positive at $6.6M, a divergence that warrants close monitoring.

The gap between net income and operating cash flow is the central signal in this dataset, as the company reported modest profits in several quarters while operating cash flow turned sharply negative. This pattern suggests that reported earnings may be substantially driven by non-cash items or working capital movements rather than underlying cash generation. Investors should monitor whether the 2025Q4 operating cash inflow of $217.5M reflects a durable improvement or a one-time timing benefit.

Working Capital Swings Drive Cash Volatility

Based on reported figures, working capital changes ranged from -$96.1M in 2026Q3 to +$171.1M in 2024Q4, indicating that receivables, inventory, and payables timing is the dominant source of quarterly cash variability at DBD.

The magnitude of working capital swings relative to net income is unusually large, suggesting that operating cash outcomes depend heavily on the timing of collections and payments rather than on steady earnings power. The 2024Q4 and 2025Q4 inflows of more than $150M each appear to be year-end effects that partly reverse in subsequent quarters. This pattern may indicate working capital management that is episodic and warrants further investigation into the drivers of receivables and payables balances.

Free Cash Flow Lumpy and Frequently Negative

As reported in financial statements, DBD's free cash flow margin ranged from -6.1% to 18.8% across the ten quarters, with the strongest quarter driven almost entirely by year-end working capital rather than a consistent operating trend.

Free cash flow margins are highly unstable, with several negative quarters offsetting the concentrated positive results in 2024Q4 and 2025Q4. Excluding those two year-end periods, the underlying free cash flow generation appears modest and frequently negative. The trajectory suggests that cash generation is not yet a reliable foundation for capital deployment or balance sheet repair.

Light Capital Intensity Limits Investment Drag

Based on EDBL-style reported figures, capital expenditure remained between 0.4% and 2.0% of revenue, a low capital intensity that means capex is not the primary cause of negative free cash flow at DBD.

Capex is consistently small relative to revenue, implying that the company's cash problems stem from operations and working capital rather than heavy reinvestment requirements. Depreciation of roughly $30M per quarter exceeds capex in nearly every period, which may indicate underinvestment relative to the asset base if sustained over time. This dynamic warrants monitoring of whether low capex reflects efficiency or deferred maintenance.

Year-End Inflows May Mask Underlying Weakness

According to recent SEC filings as summarized here, DBD's two largest operating cash inflows occurred in the fourth quarters of 2024 and 2025, which may overstate the company's typical cash generation if those periods reflect seasonal or timing effects.

Annualizing the dataset using the strongest quarters would present a materially more favorable picture than the underlying average, which is dragged down by repeated negative quarters. Stock-based compensation is modest and does not appear to materially distort operating cash flow. Investors should be cautious about extrapolating year-end cash generation without evidence that receivable collection and payables timing reflect a sustainable operating improvement.

DBD — Frequently Asked Questions

Quick answers to the most common questions about buying DBD stock.

How much cash does Diebold Nixdorf, Incorporated (DBD) generate from operations?

Diebold Nixdorf, Incorporated (DBD) generated $300.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Diebold Nixdorf, Incorporated's free cash flow?

Diebold Nixdorf, Incorporated (DBD) generated $263.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Diebold Nixdorf, Incorporated's capital expenditure (CapEx)?

Diebold Nixdorf, Incorporated (DBD) spent $61.7M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Diebold Nixdorf, Incorporated distribute cash to shareholders?

In 2025, Diebold Nixdorf, Incorporated (DBD) spent $130.7M on share repurchases. This shows the company's commitment to returning capital to its equity investors.